In 2023, the @fda.gov approved belzutifan for certain kidney cancers –– thanks to years of work led by Nobel Prize recipient William G. Kaelin Jr., MD. Now, @drchoueiri.bsky.social, director of our Lank Center for Genitourinary Oncology, and team are working to expand its clinical use.

Read SITC's latest clinical practice guideline published in the Journal for ImmunoTherapy of Cancer to view up-to-date expert recommendations on ICI treatment and management of RCC:https://ow.ly/wEZW50YzbMj Special thanks to Toni Choueiri, MD, Tian Zhang, MD and the full expert panel.

Stay in the know with #SITC! Explore our upcoming events, webinars, and important dates by looking at our calendar. Learn More: https://sitcancer.org/get-involved/events/calendar#SITC#Immunotherapy

Exciting and timely SITC sponsored “Advances” meeting! @unclineberger.bsky.social

Comprehensive and updated CPG for RCC! Great for SITC team!

The cool thing about Wyoming is how quickly you can disappear into the wilderness when you need to.

Kicking off 50 years of @unclineberger.bsky.social with @robertferrismdphd.bsky.social & the 48th Annual Scientific Symposium… looking forward to hearing the amazing reflections on #50years of #cancerresearch!

Closed out the 48th annual @unclineberger.bsky.social Scientific Symposium with incredible research & closing remarks from Shelley Earp, MD & @robertferrismdphd.bsky.social. Always in awe of the mind-blowing brain power and work of all these #cancerresearchers 🩵

Congratulations!

Everybody needs sunscreen, including people with dark skin. And we need a lot. Here is a look at what the ingredients in a sunscreen tube do. cen.acs.org/business/con... #chemsky

More than 100 immigrants from 95 countries became U.S. citizens at the home of George Washington on the Fourth of July.

Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapies @cp-cancercell.bsky.social @robertferrismdphd.bsky.social www.cell.com/cancer-cell/...

Check out this awesome body of elegant work by @lesinskilab.bsky.social @winshipatemory.bsky.social on the immune landscape of primary vs metastatic tumor of patients with pancreatic cancer. Must read!!!!

Our findings highlight the critical role of T cell trafficking to the lymph nodes in shaping neoantigen-specific antitumor responses and offers insight for improving adoptive cellular therapies www.biorxiv.org/content/10.1...

Heading 2 #AACR2025 #Chicago to talk about our work on combination #cancer #immunotherapy for #HNSCC & see what is exciting scientists from across the globe. Also looking forward to visiting @loyolachicago.bsky.social Cancer Center to talk with Prof. Michael Nishimura regarding: TCR #FinishCancer

Thank you @theaacr.bsky.social for the Waun Ki Hong Award! My talk will be addressing Precision Medicine in Renal Cell Carcinoma. See you in Chicago! cc: @danafarber.bsky.social

April is #HeadandNeckCancerAwareness Month, a reminder to learn about important #ClinicalTrials like EA3132. This #HeadandNeckCancer trial is examining a new treatment approach for pts w/ p53-mutated squamous cell carcinoma of the head & neck. bit.ly/ea3132-trial cc: @robertferrismdphd.bsky.social